Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
To evaluate CAN1012 when administered by IT injection to subjects with advanced solid tumors who are not candidates for standard therapy.
Epistemonikos ID: 9a63332ebe4b077fd38e10a62f5d2e400062e008
First added on: Oct 02, 2023